Sam-A to prove stability of Camodix suspension.

Published: 2005-11-21 06:56:00

Updated: 2005-11-21 06:56:00

Sam-A announced that the stability of Camodix suspension, a combined antibiotic of clavulanic acid and amoxicillin was verified by a study presentation titled "A comparative study for the stability of Camodix suspension tablet and dried syrup" conducted by the new drug R&D team of Seoul National ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK